Purchase Order 75P00224P00145
Award Date
9/17/24
Potential Completion Date
10/17/24
Potential Value
$22K
Federal Agency
Office of the Assistant Secretary for Administration
Awardee
Seqirus USA Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Summit, NJ 07901, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Department of Health and Human Services (HHS) to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $940,522.50 firm fixed price purchase order is for the delivery of flu vaccines. Seqirus USA Inc. has previously received awards from other federal agencies, including the Department of Defense, Department of Veterans Affairs, Department of Justice Bureau of Prisons, and the Centers for Disease Control and...
This federal contract award to Seqirus USA Inc. is for the delivery of flu vaccines. The $1,241,993.00 fixed-price purchase order was awarded on June 30, 2020 by the U.S. Department of Health and Human Services and has a completion date of July 30, 2020. Seqirus is a global biotechnology company that specializes in the manufacturing and delivery of influenza vaccines to various federal government agencies. The company has been awarded multiple Indefinite Delivery Contracts (IDCs) with agencies...
The U.S. federal government has awarded a $141,185 delivery order contract to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development, manufacturing, and delivery. The contract, with a performance period ending on August 30, 2024, is for the supply of influenza virus vaccines. Seqirus USA Inc. is the prime contractor and will be delivering the vaccines under this firm-fixed-price contract. This award is not associated with a set-aside program. Seqirus USA...
This federal contract award was issued by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Administration to Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines. The $101,795.87 firm fixed price contract is for the delivery of flu vaccines and does not have a set-aside designation. Seqirus USA Inc.'s Seqirus Usa, Inc. Division has previously held influenza vaccine contracts with various federal agencies, including the...
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccines. The contract is for the delivery of flu vaccines, with a potential value of $227,430.00. Seqirus USA Inc. has previously received contracts from various government agencies, including the Department of Defense, Department of Justice Bureau of Prisons, and Department of Health and...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services to Seqirus USA Inc., a global biotechnology company, for the delivery of influenza vaccines. The contract, valued at $1,608,584.60, does not have a set-aside designation. Seqirus USA Inc. has a history of providing influenza vaccines to various federal government customers, including the Department of Defense, Department of Veterans Affairs, Department of Justice Bureau of Prisons, and the Department...
The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price delivery order to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccines, to provide influenza vaccines. The $180,670 contract has a completion date of February 2, 2023. Seqirus, through its Seqirus USA, Inc. Division, has provided influenza vaccines to various federal government customers, including the Department of Defense, Department of Justice Bureau of Prisons, and...
This contract was awarded by the Centers for Disease Control and Prevention (CDC), an agency within the U.S. Department of Health and Human Services, to Seqirus USA Inc. through its Seqirus Usa, Inc. Division. The contract, valued at $23,480,000.00, is for the delivery of ADULT FLU vaccines. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and the Ultimate Completion Date is February 28, 2019. The contract is not designated as a set-aside. Seqirus USA Inc. is a...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration to Seqirus USA Inc., a division of Seqirus USA, Inc., to provide flu vaccines. The contract has a potential value of $109,410.00 and a completion date of October 31, 2018. Seqirus USA, Inc. is a global biotechnology company that specializes in influenza vaccines and has held several active Indefinite Delivery Indefinite Quantity (IDIQ) contracts to provide vaccines to various...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order to Seqirus USA Inc. to preorder influenza vaccines for the FY19 flu season. The $100,800.00 contract has an August 15, 2018 completion date and was awarded on March 19, 2018. Seqirus USA Inc., a global biotechnology company that specializes in influenza vaccines, will provide the required vaccines. This award is part of Seqirus' broader contract vehicles with the VA, Department of Defense,...